Balance Sheet Components - Additional Information (Details) - USD ($) |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
|
| Balance Sheet Components [Line Items] | |||
| Inventory provisions | $ 0 | $ 0 | |
| Depreciation and amortization expense | 6,000 | 12,000 | |
| Amortization expense | $ 467,000 | $ 467,000 | |
| Impairment loss on intangible assets | $ 800,000 | ||
| In process research and development | |||
| Balance Sheet Components [Line Items] | |||
| Impairment of indefinite-lived intangible assets | 4,800,000 | ||
| Fair value of IPR&D assets | $ 4,000,000 | ||
| X | ||||||||||
- Definition Balance sheet components. No definition available.
|
| X | ||||||||||
- Definition Amount of depreciation depletion and amortization of property and equipment. No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The fair value of assets acquired in noncash investing or financing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of valuation reserve for inventory. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|